HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Asking For Trouble – Posing A Question Lands Cranberry Supplement In Hot Water With Italian Ad Regulator

Executive Summary

An advertisement for a cranberry supplement which asked the question ‘Urinary tract infection?’ earned Italy's Sofar a slap on the wrist from the country's advertising regulator. The authority ruled that posing such a question was misleading consumers about the product's curative qualities.

You may also be interested in...



Cranberry Supplements Can Prevent Or Delay Recurring Cystitis – Report

Herbal cranberry supplements can prevent or delay recurrences of uncomplicated cystitis in women, says a report published by the German Institute for Quality and Efficiency in Health Care.

Implied Health Claims Ruling Indicates Tougher Stance By UK Ad Regulator

UK ad regulator ASA's ruling against Red Bull indicates a hardening approach to interpreting implied health claims. Food supplement ads that imply a "general impression of healthy living" could be caught out, warns Jessica Burt of law firm Mills & Reeve.

Italy's Recordati Takes Slice of French OTC Market With Laboratoires Tonipharm

Recordati's new private-equity owners make their first move to strengthen the Italian firm's position in Europe's OTC market by grabbing Paris-based Laboratoires Tonipharm and its leading Ginkor brand.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148480

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel